Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Omid Seidizadeh et al, published in Nature Scientific Reports, adding:
”How common is von Willebrand disease?
Far more prevalent than registries indicate.
A new Nature study uses gnomAD v4.1 (807,000+ sequenced individuals) and Hardy–Weinberg genetic modeling on 321 pathogenic/likely pathogenic VWF variants to refine the global genetic prevalence of von Willebrand disease (VWD).
By filtering 10,397 VWF variants down to this high‑confidence pathogenic set and applying Hardy–Weinberg models, the authors report a strikingly high global prevalence:
- approximately 11 per 1,000 for type 1 (≈1.1% of the population)
- 1.3–1.7 per 1,000 for dominant type 2 variants (2A, 2B, 2M)
- Tens per million for recessive forms (≈34 per million for 2N and ≈1–2 per million for type 3)
- Altogether, this translates into tens of millions of affected individuals worldwide.
The study further maps pathogenic variant clustering across functional VWF domains and highlights ancestry‑specific distributions of key alleles, underscoring both shared VWF biology and population‑specific risk patterns.
For clinical and research practice, these data provide a valuable reference for variant interpretation, support more realistic registry and screening strategies, and reinforce that VWD—particularly mild and qualitative forms—remains substantially underdiagnosed and undertreated.
Congratulations to Omid Seidizadeh, Andrea Cairo, Camilla Oriani and Flora Peyvandi.”
Title: Updated global prevalence and ethnic diversity of von Willebrand disease based on population genetics analysis
Authors: Omid Seidizadeh, Andrea Cairo, Camilla Oriani, Flora Peyvandi

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 18, 2026, 15:40Marc Carrier: New ISTH 2026 Data May Simplify DVT Evaluation During Pregnancy
-
Jul 18, 2026, 15:38Hermine Sayiyan: Dreams Do Come True – Often When We Least Expect Them
-
Jul 18, 2026, 15:31Alyaa Al-Mughairy: Presenting Real-World Emicizumab Data at the ISTH 2026 Middle East Summit
-
Jul 18, 2026, 15:25Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
-
Jul 18, 2026, 15:22Owen McCarty: Honored to Speak at the 1st Mediterranean Platelet Symposium
-
Jul 18, 2026, 15:18Strengthening Regional Learning for Hemophilia and Sickle Cell Disease Care – Novo Nordisk
-
Jul 18, 2026, 14:54Fabien Mselati: Reflecting on 25 Years of Hemophilia Progress
-
Jul 18, 2026, 14:50Nikola Pantic: Grateful for the People Who Made ISTH 2026 Special
-
Jul 18, 2026, 14:30Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress